Straumann Holding AG Operating Income 2012-2024 | SAUHY

Straumann Holding AG annual/quarterly operating income history and growth rate from 2012 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Straumann Holding AG operating income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG operating income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Straumann Holding AG annual operating income for 2024 was $0.683B, a 49.13% increase from 2023.
  • Straumann Holding AG annual operating income for 2023 was $0.458B, a 18.4% decline from 2022.
  • Straumann Holding AG annual operating income for 2022 was $0.561B, a 5.5% decline from 2021.
Straumann Holding AG Annual Operating Income
(Millions of US $)
2024 $683
2023 $458
2022 $561
2021 $594
2020 $167
2019 $390
2018 $350
2017 $288
2016 $231
2015 $180
2014 $162
2013 $122
2012 $63
2011 $87
Straumann Holding AG Quarterly Operating Income
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.704B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65